Comparison of 2-Dose and 3-Dose 9-Valent Human Papillomavirus Vaccine Schedules in the United States: A Cost-effectiveness Analysis.
about
Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial.Modeling of US Human Papillomavirus (HPV) Seroprevalence by Age and Sexual Behavior Indicates an Increasing Trend of HPV Infection Following the Sexual Revolution.Use of a 2-Dose Schedule for Human Papillomavirus Vaccination-Updated Recommendations of the Advisory Committee on Immunization Practices.Missed opportunities for HPV immunization among young adult women.Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country
P2860
Comparison of 2-Dose and 3-Dose 9-Valent Human Papillomavirus Vaccine Schedules in the United States: A Cost-effectiveness Analysis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Comparison of 2-Dose and 3-Dos ...... A Cost-effectiveness Analysis.
@en
type
label
Comparison of 2-Dose and 3-Dos ...... A Cost-effectiveness Analysis.
@en
prefLabel
Comparison of 2-Dose and 3-Dos ...... A Cost-effectiveness Analysis.
@en
P2093
P2860
P356
P1476
Comparison of 2-Dose and 3-Dos ...... A Cost-effectiveness Analysis.
@en
P2093
Harrell W Chesson
Jean-François Laprise
Marc Brisson
Mélanie Drolet
P2860
P304
P356
10.1093/INFDIS/JIW227
P407
P577
2016-05-27T00:00:00Z